| Literature DB >> 31601222 |
Richard Thomson-Luque1, John H Adams2, Clemens H M Kocken3, Erica M Pasini4.
Abstract
Historically neglected, due to its biological peculiarities, the absence of a continuous long-term in vitro blood stage culture system and a propensity towards high morbidity rather than mortality, Plasmodium vivax was put back on the agenda during the last decade by the paradigm shift in the fight against malaria from malaria control to malaria eradication. While the incidence of the deadliest form of malaria, Plasmodium falciparum malaria, has declined since this paradigm shift took hold, the prospects of eradication are now threatened by the increase in the incidence of other human malaria parasite species. Plasmodium vivax is geographically the most widely distributed human malaria parasite, characterized by millions of clinical cases every year and responsible for a massive economic burden. The urgent need to tackle the unique biological challenges posed by this parasite led to renewed efforts aimed at establishing a continuous, long-term in vitro P. vivax blood stage culture. Based on recent discoveries on the role of nutrient sensing in Plasmodium's pathophysiology, this review article critically assesses the extensive body of literature concerning Plasmodium culture conditions with a specific focus on culture media used in attempts to culture different Plasmodium spp. Hereby, the effect of specific media components on the parasite's in vitro fitness and the maturation of the parasite's host cell, the reticulocyte, is analysed. Challenging the wide-held belief that it is sufficient to find the right parasite isolate and give it the right type of cells to invade for P. vivax to grow in vitro, this review contends that a healthy side-by-side maturation of both the parasite and its host cell, the reticulocyte, is necessary in the adaptation of P. vivax to in vitro growth and argues that culture conditions and the media in particular play an essential role in this maturation process.Entities:
Keywords: Continuous long-term blood-stage culture; Malaria; Medium; Plasmodium vivax
Mesh:
Substances:
Year: 2019 PMID: 31601222 PMCID: PMC6785855 DOI: 10.1186/s12936-019-2949-x
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Fig. 1Diagram of the processes occurring during P. vivax long-term in vitro blood stage culture. Depiction of processes involved in the development of the parasite (invasion, maturation and egress) and the reticulocytes (maturation) including healthy progression and road-blocks observed in P. vivax in vitro long-term culture attempts. a The healthy erythroid cell maturation from orthochromatic erythroblast in the bone marrow to mature red blood cell is depicted. During this process the erythroid cell first expels the nucleus in form of pyrenocyte. Thereafter, it loses the mitochondria, different surface proteins (including the CD71) and, finally, the reticulum and the ribosomes. b The healthy maturation of P. vivax is depicted from rings to trophozoites to schizonts and the egress of merozoites. c The tropism of P. vivax merozoites for the different cell-types produced during the healthy erythroid maturation is examined and depicted using different arrow colors for high, medium, low. d The joint development of P. vivax parasite and the reticulocytes they have invaded is portrayed including anomalies in P. vivax invasion (adhesion but no invasion) and development (picnotic rings, lack of proper maturation of schizonts), which result in no progression and are marked by a red star
Fig. 2Natural and P. vivax-driven reticulocyte remodelling of infected reticulocytes in vitro. Proposed host structures that need to be correctly formed at the P. vivax-reticulocyte membrane interface for a healthy side-by-side development of parasite and host cell within the in vitro culture
Fig. 3Morfological events characteristics of P. vivax in vitro culture failure (images: RTL). a Non progressive rings (picnotic), b altered trophozoite formation, c inhability to replicate, d unpacking trophozoite, e schizont dismemberment, f lack of egress, g reticulocyte membrane desintegration and h no merozoite invasión
Comparison of the components of the 3 historically most-used media in attempts aimed at culturing P. vivax in vitro
Media composition of RPMI-1640, Waymouth and McCoy5A from commonly available commercial brands. Shadowed are components of special interest. Waymouth medium is available either powder or liquid and it is highly enriched in amino-acids, ascorbic acid and glutathione. With a higher concentration in glucose than most other commercial media. It is also the only medium used for cultivating P. vivax that includes hypoxanthine in its formulation. RPMI-1640 can be sourced in either its powder or liquid forms from a number of different companies. Modified versions of this medium are also commercially available: in such versions the RPMI-1640 is typically supplemented with or depleted of l-glutamine, sodium bicarbonate, HEPES (15 mM, 20 mM or 25 mM), folic acid, methionine, cysteine, Glutamax as well as different amounts of glucose. Special formulations known as the ATCC modification (containing high glucose, low sodium bicarbonate, sodium pyruvate, HEPES, and low l-glutamine) or the Dutch modification (addition of HEPES, with lower sodium bicarbonate (1 g/L)) are also obtainable. McCoy’s 5A, unlike other media, contains bacto-peptone, and high levels of glucose. Moreover, it contains high levels of folic acid and thiamine while the levels of cysteine and leucine are reduced compared to other media formulations. McCoy5A contains no magnesium chloride and lower levels of glutathione compared to RPMI and Waymouth. Last, McCoy5A comprises an increased concentration of pABA, and folic acid compared to different commercially available RPMI and Waymouth media. Commercially available in powder and liquid forms too, it includes variant formulations comprising the addition of HEPES, Glutamax, l-glutamine and extra sodium bicarbonate
Proposed systematic comparisons needed to unravel key avenues for the development of a continuous in vitro culture system for P. vivax blood stages
| Media component | Proposed systematic comparisons with current practice | Expected effect on the parasite | Expected effect on the reticulocyte | Media formulation to accomplish proposed action | References |
|---|---|---|---|---|---|
| Earle’s salts + reduce sodium bicarbonate to 0.85 g/L | Optimal buffering capacity: parasite healthy maturation | Reticulocyte healthy maturation | RPMI Dutch’s modification | Never tested | |
| amino acids + mixture of sugars; no sodium bicarbonate | Optimal buffering capacity: parasite healthy maturation | Reticulocyte healthy maturation | L15 and SR1-8 | [ | |
| HEPES 20 mM | Optimal buffering capacity: parasite healthy maturation | Reticulocyte healthy maturation | [ | ||
| Inorganic salts | Ionic strength of 12.6–12.80 mS/cm | Better segmentation | Reticulocyte healthy maturation | Waymouth | [ |
| Increase Magnesium chloride 1.8 mM | Increased parasite viability | Appropriate conformation of surface proteins | Waymouth/L15 | [ | |
| Addition of calcium pantothenate | Enhanced parasite survival and multiplication | If any, unknown | SCMI 612 | [ | |
| Addition of manganese | Enhanced parasite invasion | Appropriate conformation of surface proteins | [ | ||
| GlutaMAX | Does not break down to form toxic ammonia: better progression to late stages | Reticulocyte healthy maturation | Commercial McCoy5A/RPMI commercial + glutamax | [ | |
| Increase leucine, phenylalanine, valine, isoleucine and methionine | Parasite growth and detoxification of the toxic free heme | Healthy reticulocytes | In most media formulations; concentration may vary | [ | |
| Amino acids | Ascorbic acid | Enhanced parasite survival and multiplication | Healthy reticulocytes: helps to keep proper redox equilibrium | In most media formulations; concentration may vary | [ |
| Orotic acid | Enhances parasite redox stability | Healthy reticulocytes: helps to keep proper redox equilibrium | Needs to be added, concentration to be determined | [ | |
| Vitamins | pABA concentrations | Enhanced intracellular development and maturation | Healthy reticulocytes | Most appropriate concentration to be determined | [31, 128.130] |
| Piridoxyne/pyridoxal hydrocholoride | Enhanced intracellular development and maturation | Healthy reticulocytes | IMDM has highest concentration at 4 g/L | [ | |
| Serum | Use serum (ideally commercial); serum is likely better than Albumax | Supporting parasite viability | Membrane integrity and maturation | Commercial serum is desirable for inter laboratory standardization | [ |
| Antibiotics | Gentamicin/other antibiotics | Possible toxicity on specific parasite species and strains | If any, unknown | [ | |
| Hypoxanthine | Necessary | Parasite maturation | If any, unknown | Waymouth, DMEM/F12 | [ |
| Lipid | Addition of fatty acids, choline, myo-inositol, ethanolamine, lyso-PC | Parasite survival, maturation and multiplication | Membrane integrity and maturation | Needs to be added, concentration to be determined | [ |
| Cholesterol | Use lipoproteins containing cholesterol instead of free cholesterol | Parasite maturation and eggress | Membrane integrity and maturation | Needs to be added, concentration to be determined | [ |
Expected effects of proposed approaches on both the parasite and the reticulocyte
Box 1Summary of the proposed paradigm shift necessary to allow Plasmodium vivax long-term in vitro growth. Diagram explaining the necessary combination of two historically distinct focused approaches and postulating the need for a physiological maturation of both, the parasites and its host cell (reticulocyte) side-by-side to achieve a continuous, long-term in vitro P. vivax blood stage culture
Fig. 4Progression of a healthy, short-term (5 days) P. vivax in vitro culture: T0 h rings, T20 h and T42 h (corresponding to a first cycle of in vitro cultivation; (D) T68 h, and T92 h corresponding to a second cycle of in vitro cultivation); and T116 h (corresponding to a third cycle of in vitro cultivation)